AAAAAA

   
Results: 1-3 |
Results: 3
START OF THERAPY WITH THE ANGIOTENSIN-II ANTAGONIST LOSARTAN AFTER IMMEDIATE SWITCH FROM PRETREATMENT WITH AN ACE-INHIBITOR
Authors: SCHOLZE J STAPFF M
Citation: J. Scholze et M. Stapff, START OF THERAPY WITH THE ANGIOTENSIN-II ANTAGONIST LOSARTAN AFTER IMMEDIATE SWITCH FROM PRETREATMENT WITH AN ACE-INHIBITOR, British journal of clinical pharmacology, 46(2), 1998, pp. 169-172
EFFICACY, SAFETY, AND EFFECTS ON HYPERTENSION-ASSOCIATED SYMPTOMS OF LOSARTAN, ALONE OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE, VERSUS AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION
Authors: TIEBEL R VAHLBRUCH A STAPFF M
Citation: R. Tiebel et al., EFFICACY, SAFETY, AND EFFECTS ON HYPERTENSION-ASSOCIATED SYMPTOMS OF LOSARTAN, ALONE OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE, VERSUS AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, Current therapeutic research, 59(6), 1998, pp. 325-340
LOSARTAN AND EXP-3174 IN RATS - CONCENTRATIONS IN CENTRAL AND PERIPHERAL COMPARTMENTS AS BASIS FOR PK PD CORRELATIONS/
Authors: SOLDNER A SPAHNLANGGUTH H VOITH B STAPFF M MUTSCHLER E
Citation: A. Soldner et al., LOSARTAN AND EXP-3174 IN RATS - CONCENTRATIONS IN CENTRAL AND PERIPHERAL COMPARTMENTS AS BASIS FOR PK PD CORRELATIONS/, The FASEB journal, 10(3), 1996, pp. 996-996
Risultati: 1-3 |